-
81.
公开(公告)号:US10213765B2
公开(公告)日:2019-02-26
申请号:US15603285
申请日:2017-05-23
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Martin Hall , Sture Larsson , Andreas Muranyi , Gustav Rodrigo , Jinyu Zou , Per-Mikael Aberg
IPC: C07K1/22 , B01D15/38 , B01J20/24 , B01J20/286 , B01J20/32 , C07K14/31 , C07K16/00 , C07K17/00 , B01J20/28 , B01J20/285 , B01J20/289 , C07K17/10
Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates to a process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
-
公开(公告)号:US10189891B2
公开(公告)日:2019-01-29
申请号:US14385336
申请日:2013-03-26
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Mats Ander , Goran Bauren , Tomas Bjorkman , Per-Mikael Aberg , Gustav Rodrigo
IPC: C07K1/22 , C07K14/31 , C07K16/00 , B01J20/286 , B01D15/38 , B01J20/291 , G01N33/68 , B01J20/32
Abstract: The invention discloses an immunoglobulin-binding protein comprising one or more mutated immunoglobulin-binding domains (monomers) of staphylococcal Protein A (E, D, A, B, C) or protein Z or a functional variant thereof, wherein in at least one of the one or more mutated monomers, the asparagine or histidine at the position corresponding to H18 of the B domain of Protein A or of Protein Z has been deleted or substituted with a first amino acid residue which is not proline or asparagine and wherein, if the amino acid residue at position 57 is proline and the amino acid residue at position 28 is asparagine, then the amino acid residue at the position corresponding to H18 of the B domain of protein A or of protein Z is not serine, threonine or lysine.
-
公开(公告)号:US20180361272A1
公开(公告)日:2018-12-20
申请号:US15781305
申请日:2016-12-07
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Dan Hermansson , Klaus Gebauer , Mats Lundkvist
Abstract: The invention discloses a chromatography column module stackable with like chromatography modules, comprising a column chamber (2) fluidically connected to a column inlet 3) and a column outlet (4), wherein the column inlet and outlet each comprise a valve (5), arranged to move from a closed position to an open position upon connection of the column inlet or outlet with a) a column outlet or inlet of a like chromatography module or b) with an outlet or inlet of a fluidics plate. The invention further discloses a stack of chromatography column modules and the use of the stack for separation of biomolecules.
-
公开(公告)号:US10092856B2
公开(公告)日:2018-10-09
申请号:US15793923
申请日:2017-10-25
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Klaus Gebauer
Abstract: A parallel assembly (2; 11; 51) of chromatography column modules (3a,b,c; 13a,b,c; 53a,b,c, 90a, b), the assembly having one common assembly inlet (15; 55) and one common assembly outlet (17; 57), each column module comprising a bed space (29) filled with chromatography medium and each column module comprises integrated fluid conduits which when the column module is connected with other column modules are adapted to connect the bed space (29) of the column module with the assembly inlet (15; 55) and the assembly outlet (17; 57), wherein the total length and/or volume of the fluid conduit from the assembly inlet to one bed space together with the length and/or volume of the fluid conduit from the same bed space to the assembly outlet is substantially the same for all bed spaces and modules installed in the parallel assembly.
-
公开(公告)号:US20180224439A1
公开(公告)日:2018-08-09
申请号:US15428342
申请日:2017-02-09
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Robert Karlsson
IPC: G01N33/543 , G06F19/26
CPC classification number: G16B45/00 , G01N33/54373 , G01N33/557 , G16B20/00 , G16B40/00
Abstract: The present invention relates to a method of evaluation of molecular binding interactions at a sensing surface, and more particularly to a method for evaluation of screening data obtained from an interaction between an analyte in a fluid sample and a ligand immobilized on a sensor surface of a biosensor that is independent of interaction models. Preferably the biosensor is a SPR biosensor.The invention also relates to a biosensor system arranged to perform the method and a computer program arranged to control the operation of the biosensor system.
-
公开(公告)号:US20180223003A1
公开(公告)日:2018-08-09
申请号:US15937428
申请日:2018-03-27
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Mattias Algotsson , Lars C. Andersson , Eggert Brekkan , Lee Hedemyr , Jean-Luc Maloisel , Ronnie Palmgren
IPC: C08B37/00 , C07C323/60 , C07C237/10 , B01J20/32 , B01J20/281 , B01J20/289
CPC classification number: C08B37/0039 , B01J20/281 , B01J20/289 , B01J20/3219 , B01J20/3251 , B01J20/3265 , C07C237/10 , C07C323/60
Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
-
公开(公告)号:US20180127459A1
公开(公告)日:2018-05-10
申请号:US15564224
申请日:2016-04-04
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Martin Hall , Mikael Berg , Ida Eklind , Sandeep Kristiansson
IPC: C07K1/18 , C07K14/755 , A61P7/00 , B01D15/36
CPC classification number: C07K1/18 , A61K38/00 , A61P7/00 , B01D15/363 , C07K14/755
Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of Factor VIII and von Willebrand factor from a cryoprecipitate of plasma. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
-
88.
公开(公告)号:US20170259244A1
公开(公告)日:2017-09-14
申请号:US15603285
申请日:2017-05-23
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Martin Hall , Sture Larsson , Andreas Muranyi , Gustav Rodrigo , Jinyu Zou , Per-Mikael Aberg
IPC: B01J20/24 , C07K14/31 , C07K17/10 , B01D15/38 , B01J20/28 , B01J20/285 , B01J20/289 , B01J20/32 , C07K1/22 , C07K16/00
CPC classification number: B01J20/24 , B01D15/3809 , B01J20/28019 , B01J20/285 , B01J20/286 , B01J20/289 , B01J20/3212 , B01J20/3219 , B01J20/3274 , B01J20/3293 , B01J2220/52 , B01J2220/54 , C07K1/22 , C07K14/31 , C07K16/00 , C07K17/00 , C07K17/10 , C07K2317/55
Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIF) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
-
公开(公告)号:US09657055B2
公开(公告)日:2017-05-23
申请号:US14358821
申请日:2012-11-28
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Hans J. Johansson , Ronnie Palmgren
IPC: B01D15/38 , C07K1/22 , C07K14/31 , C07K19/00 , B01J20/286 , B01J20/32 , C07K14/245 , B01D15/34
CPC classification number: C07K1/22 , B01D15/34 , B01D15/3809 , B01J20/285 , B01J20/286 , B01J20/289 , B01J20/3274 , C07K14/245 , C07K14/31 , C07K2319/00
Abstract: The invention discloses a polypeptide capable of binding immunoglobulins or immunoglobulin-containing proteins, which polypeptide comprises six or more domains of protein Z or the C domain of protein A or a functional variant thereof. It also discloses separation matrices comprising the polypeptide and methods of using the separation matrices for separation of immunoglobulins or immunoglobulin-containing proteins.
-
公开(公告)号:US20170067031A1
公开(公告)日:2017-03-09
申请号:US15355675
申请日:2016-11-18
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Patrik Adielsson , Tobias E. Soderman , Anna Akerblom
CPC classification number: C12N7/00 , B01D15/3847 , C12N2760/16151
Abstract: The present invention relates to a method for endotoxin removal from a sample comprising the following steps: combining the sample comprising one or more target molecule(s) with a chromatography media comprising beads having an inner porous core functionalized with ligands capable of binding endotoxin and an outer porous layer without functional groups and a pore size small enough to exclude the target molecule from the inner core; and collecting the sample from the media, wherein the sample comprises an endotoxin level which is at least 75% less, preferably 90% less, than before the removal and the yield of the target molecule is at least 75%.
Abstract translation: 本发明涉及一种从样品中去除内毒素的方法,包括以下步骤:将包含一种或多种靶分子的样品与包含珠的色谱介质组合,所述珠粒具有由能够结合内毒素的配体功能化的内部多孔核心和 没有官能团的外部多孔层和足够小以从靶芯排出靶分子的孔径; 并从培养基中收集样品,其中样品包含与去除前相比至少75%以上,优选90%以下的内毒素水平,并且目标分子的产率为至少75%。
-
-
-
-
-
-
-
-
-